Cardinal Health Profit Margin 2011-2025 | CAH

Current and historical gross margin, operating margin and net profit margin for Cardinal Health (CAH) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Cardinal Health net profit margin as of September 30, 2025 is 0.68%.
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $47.087B $222.578B
Cardinal Health Inc. is a nation-wide drug distributor and provider of services to pharmacies, healthcare providers and manufacturers. The company has two reporting segments: Pharmaceutical and Medical. The Pharmaceutical segment is the second largest pharmaceutical distributor in the United States and the largest nuclear pharmacy. Its products and services include pharmaceutical distribution, manufacturer and specialty services, and nuclear and pharmacy services. The Medical segment manufactures products such as single-use surgical drapes, gowns and apparel; exam and surgical gloves; and fluid suction and collection systems and offers sterile and non-sterile procedure kits. These products are sold directly or distributed via third-party sources in the U.S., Canada, Europe, South America and the Asia/Pacific.?
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $100.445B 22.44
Becton Dickinson (BDX) United States $57.338B 13.93
West Pharmaceutical Services (WST) United States $19.249B 37.84
Straumann Holding AG (SAUHY) Switzerland $19.119B 0.00
Cooper (COO) United States $16.086B 19.87
Align Technology (ALGN) United States $11.870B 22.42
Henry Schein (HSIC) United States $9.012B 15.88
Merit Medical Systems (MMSI) United States $5.140B 25.28
DENTSPLY SIRONA (XRAY) United States $2.308B 7.32
CONMED (CNMD) United States $1.264B 9.03
STAAR Surgical (STAA) United States $1.200B 0.00
Pro-Dex (PDEX) United States $0.142B 16.88
Lifevantage (LFVN) United States $0.083B 7.83